Sangeeta Adak

613 citations
18 papers · 406 indexed · h-index 12
Topics
Peroxisome Proliferator-Activated Receptors (4 papers)Cancer, Lipids, and Metabolism (3 papers)HER2/EGFR in Cancer Research (3 papers)
Partner nations
United StatesIndiaChina

In The Last Decade

Sangeeta Adak

18 papers receiving 403 citations

Peers

Sangeeta Adak
Comparison fields: 5 of 81
  • Molecular Biology 214
  • Oncology 70
  • Physiology 69
  • Immunology 51
  • Cell Biology 49
Replace Doo Jae Lee with:
Doo Jae Lee South Korea
Yu Geng China
Joseph B. Lin United States
Thomas Estridge United States
Yachao Yao China
Anton J. Aarsman Netherlands
Shilong You China
Takahiro Terami Japan
Ming Yan China
Raeeka Khamari France
Sangeeta Adak relative to Doo Jae Lee South Korea Doo Jae Lee's profile →
Citations per field
00.5×1.5×2.3×
Doo Jae Lee · 1×
Citations per year

Countries citing papers authored by Sangeeta Adak

Since Specialization
Citations

This map shows the geographic impact of Sangeeta Adak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sangeeta Adak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sangeeta Adak more than expected).

Fields of papers citing papers by Sangeeta Adak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sangeeta Adak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sangeeta Adak. The network helps show where Sangeeta Adak may publish in the future.

Co-authorship network of co-authors of Sangeeta Adak

This figure shows the co-authorship network connecting the top 25 collaborators of Sangeeta Adak. A scholar is included among the top collaborators of Sangeeta Adak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sangeeta Adak. Sangeeta Adak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 2
2 6
3 1
4 41
5 6
6 7
7 32
8 38
9 18
10 18
11 88
12 30
13 20
14 16
15 20
16 35
17 21
18 7

About Sangeeta Adak

Sangeeta Adak is a scholar working on Cancer Research, Cell Biology and Ophthalmology, having authored 18 papers that have together received 406 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (4 papers), Cancer, Lipids, and Metabolism (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Clinical Biochemistry (22 citations), Molecular Biology (214 citations) and Cell Biology (49 citations). Sangeeta Adak has collaborated with scholars based in United States, India and China. Frequent co-authors include Clay F. Semenkovich, Maitree Bhattacharyya, Subhankar Chowdhury, Xiaochao Wei, Linda J. Pike, Feng Chu, Fong‐Fu Hsu, Jennifer L. Macdonald-Obermann, Grazia Abou‐Ezzi and Daniel C. Link. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026